Literature DB >> 14116210

[ON THERAPY-RESISTANT EPILEPTICS].

I VON HEDENSTROEM, G SCHORSCH.   

Abstract

Entities:  

Keywords:  ANTICONVULSANTS; ELECTROENCEPHALOGRAPHY; EPILEPSY; NEUROLOGIC MANIFESTATIONS; VENTRICULOGRAPHY

Mesh:

Substances:

Year:  1963        PMID: 14116210     DOI: 10.1007/BF00352712

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr        ISSN: 0003-9373


× No keyword cloud information.
  15 in total

1.  An analysis of the results of treatment in epileptics under ambulatory supervision.

Authors:  E FRANTZEN
Journal:  Epilepsia       Date:  1961-06       Impact factor: 5.864

2.  The drug therapy of convulsive seizures.

Authors:  M D YAHR; H H MERRIT
Journal:  Int J Neurol       Date:  1959-12

3.  Prognosis in convulsive disorders.

Authors:  R R STROBOS
Journal:  Arch Neurol       Date:  1959-08

4.  [Studies on the course of seizures & EEG in epilepsy in children].

Authors:  R HESS
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1958

5.  [Catamnestic studies & EEG in pyknolepsy].

Authors:  G PAAL
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1957

6.  [Problems and experiences with termination of anticonvulsive therapy].

Authors:  C ZENKER; C GROH; G ROTH
Journal:  Neue Osterr Z Kinderheilkd       Date:  1957

7.  [Bioelectric studies in animals with epileptogenic lesions].

Authors:  K SCHMALBACH; H W STEINMANN
Journal:  Dtsch Z Nervenheilkd       Date:  1955

8.  [Experimental animal studies on the radiation of epileptic excitation. III. Persistent after-discharge in focal electric brain stimulation, with comments on the methodology of study of functional brain structure].

Authors:  R JANZEN; E MULLER; F BECHER
Journal:  Dtsch Z Nervenheilkd       Date:  1954

9.  [Epilepsy in children and adolescents].

Authors:  W SPIEL; H STROTZKA
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1954

10.  Significance of febrile convulsions.

Authors:  W G LENNOX
Journal:  Pediatrics       Date:  1953-04       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.